Company Profile

Company Overview

Since its founding in 2007 by world leaders in cancer biology, molecular diagnostics and personalized medicine, Metamark has evolved into a trailblazer in clinical proteomics – the study of proteins and protein signatures within healthy and diseased cells. With the acquisition of HealthTronics Laboratory Solutions in 2013, a national provider of specialized anatomic and clinical uropathology testing services, Metamark became a leader in the diagnosis and management of prostate cancer, cancer of the bladder, and other urologic conditions.